SEC Form 4 · accession 0001839066-26-000017
CLOVER HEALTH INVESTMENTS, CORP. /DE · CLOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jamie L. Reynoso
Officer — CEO, Medicare Advantage
Period of report
Jun 11, 2026
Accepted (ET)
Jun 11, 2026 · 5:28 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001801170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 11, 2026 | S | 7,289 | $4.91 | D | 2,849,921 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks: